Cargando…

Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant

BACKGROUND: The Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) is a new validated 14-item patient-reported outcome (PRO) instrument for evaluating daytime functioning in people with insomnia. It comprises three domains: Alert/Cognition, Mood, and Sleepiness. OBJECTIVE: The aim of this a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips-Beyer, Andrea, Kawata, Ariane K., Kleinman, Leah, Kinter, Dalma Seboek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314845/ https://www.ncbi.nlm.nih.gov/pubmed/37286927 http://dx.doi.org/10.1007/s40290-023-00484-w

Ejemplares similares

Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
por: Hudgens, Stacie, et al.
Publicado: (2020)

Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
por: Hudgens, Stacie, et al.
Publicado: (2023)

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
por: Kunz, Dieter, et al.
Publicado: (2022)

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
por: Di Marco, Tobias, et al.
Publicado: (2023)

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial
por: Fietze, Ingo, et al.
Publicado: (2022)

Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials
por: Heidenreich, Sebastian, et al.
Publicado: (2022)

Daridorexant in Insomnia Disorder: A Profile of Its Use
por: Nie, Tina, et al.
Publicado: (2023)

Correction to: Daridorexant in Insomnia Disorder: A Profile of Its Use
por: Nie, Tina, et al.
Publicado: (2023)

Use of Daridorexant among Patients with Chronic Insomnia: A Retrospective Observational Analysis
por: Williams, Scott G., et al.
Publicado: (2023)

Daridorexant: First Approval
por: Markham, Anthony
Publicado: (2022)

Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
por: Roch, Catherine, et al.
Publicado: (2021)

Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023)

Correction to: Daridorexant: First Approval
por: Markham, Anthony
Publicado: (2022)

Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials
por: Jiang, Feiyu, et al.
Publicado: (2023)

A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
por: Ziemichód, Wojciech, et al.
Publicado: (2022)

Comparison of sleep microarchitecture in screen failure subjects with insomnia complaints and randomized subjects from two phase 3 studies on insomnia disorder
por: Di Marco, T., et al.
Publicado: (2023)

Enhanced Vigilance Stability during Daytime in Insomnia Disorder
por: Losert, Ariane, et al.
Publicado: (2020)

Do Insomnia Treatments Improve Daytime Function?
por: Watson, Nathaniel F., et al.
Publicado: (2023)

Correlates of daytime sleepiness and insomnia among adults in Samoa
por: Heinsberg, Lacey W., et al.
Publicado: (2022)

Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment
por: Berger, Benjamin, et al.
Publicado: (2021)

Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator
por: Muehlan, Clemens, et al.
Publicado: (2022)

Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist
por: Krause, Andreas, et al.
Publicado: (2022)

Network analysis to estimate central insomnia symptoms among daytime workers at-risk for insomnia
por: Takano, Yuta, et al.
Publicado: (2023)

Social outbreak and its association with insomnia and daytime sleepiness in Chile
por: Pizarro-Mena, Rafael Andrés, et al.
Publicado: (2022)

Hypomagnesemia Is Associated with Excessive Daytime Sleepiness, but Not Insomnia, in Older Adults
por: Tunc, Muhammed, et al.
Publicado: (2023)

Examination of Daytime Sleepiness and Cognitive Performance Testing in Patients with Primary Insomnia
por: Liu, Hong, et al.
Publicado: (2014)

Daytime Neurophysiological Hyperarousal in Chronic Insomnia: A Study of qEEG
por: Oh, Da Young, et al.
Publicado: (2020)

Insomnia and excessive daytime sleepiness in medical students: consequences of the use of technologies?
por: Cardoso, Gabriela Miloch da Silva, et al.
Publicado: (2022)

The mortality risk of night-time and daytime insomnia symptoms in an older population
por: Harvey, Amy, et al.
Publicado: (2023)

Evaluation of Patient Preference and Willingness to Pay for Attributes of Maintenance Medication for Chronic Obstructive Pulmonary Disease (COPD)
por: Kawata, Ariane K., et al.
Publicado: (2014)

The Sleep Impact on Activity Diary (SIAD): A Novel Assessment of Daytime Functioning in Insomnia
por: Bickley, Kelsey, et al.
Publicado: (2021)

Overnight Delta Dynamics Associated with Daytime Psychomotor Performance in Adults with Insomnia and Healthy Controls
por: Lunsford-Avery, Jessica R, et al.
Publicado: (2022)

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine
por: Ford, Janet H., et al.
Publicado: (2023)

Insomnia, Daytime Sleepiness and Cardio-Cerebrovascular Diseases in the Elderly: A 6-Year Prospective Study
por: Jaussent, Isabelle, et al.
Publicado: (2013)

Association of insomnia and daytime sleepiness with low back pain: A bidirectional mendelian randomization analysis
por: Shu, Peng, et al.
Publicado: (2022)

P056 Improvements in Daytime Function Items of the Insomnia Severity Index Are Correlated with a Positive Impact of Treatment on the Patient Global Impression Insomnia Scale
por: Drake, C, et al.
Publicado: (2023)

Insomnia, excessive daytime sleepiness, anxiety, depression and socioeconomic status among customer service employees in Canada
por: Etindele-Sosso, Faustin Armel
Publicado: (2020)

High-dose Vitamin D Supplementation and Improvement in Cognitive Abilities, Insomnia, and Daytime Sleepiness in Adolescent Girls
por: Bahrami, Afsane, et al.
Publicado: (2021)

Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderly
por: Cavaillès, Clémence, et al.
Publicado: (2022)

Associations between Insomnia, Daytime Sleepiness, and Depressive Symptoms in Adolescents: A Three-Wave Longitudinal Study
por: Liu, Xianchen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lm137dvahqsdbdo1hvv679p09n